Little Evidence to Support Use of Pricey Repository Corticotropin Little Evidence to Support Use of Pricey Repository Corticotropin

Repository corticotropin costs much more than corticosteroids, but shows little clinical benefit over them, results of a scoping review suggest.Reuters Health Information
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Rheumatology News Source Type: news